金陵药业股份有限公司2025年第三季度报告

Core Points - The company guarantees the authenticity, accuracy, and completeness of the information disclosed in its quarterly report [2][21][42] - The third-quarter financial report has not been audited [3][10][11] - The company has made retrospective adjustments to its financial data due to a merger under common control [42][43][45] Financial Data - The company has undergone a retrospective adjustment of financial data due to the acquisition of additional shares in a medical investment fund, increasing its stake from 33.33% to 78.46% [42][43] - The adjustments will reflect in the consolidated profit and cash flow statements for the previous year [44] Shareholder Information - The company will hold its third extraordinary general meeting on November 13, 2025, with provisions for both on-site and online voting [50][51][52] - The meeting will address several proposals, including amendments to the company's articles of association and rules for shareholder meetings [27][29][30] Board and Supervisory Committee Actions - The board and supervisory committee have approved the retrospective adjustment of financial data and the third-quarter report [14][16][34][36] - The board has also approved the signing of a technology transfer contract [30]